Pharmaceutical Strategies, part of the Empresaria Group operating across the US, has been identified as a Premier Partner of TAPFIN for a second year in a row.
Key areas in which Pharmaceutical Strategies excelled, and thus contributed to the receipt of this prestigious accreditation include areas of efficiency, quality, cost, and risk compliance in the top 50 of all suppliers' performance.
The hard work and diligence of those in Pharmaceutical Strategies puts them in the top 4% of all vendors TAPFIN selected in 2018 as our Top Partners.
Elisa Ciardiello, CEO of Pharmaceutical Strategies commented:
"It has been an honour to work with the Tapfin Teams for the past 11 years. I am proud to announce they have awarded us as a Premier Partner of 2018 for the second year in a row. A Premier Partner is in the top 45 performers who received positive feedback from the Tapfin team. We look forward and are excited to continue our Partnership in 2019. Thank you to Lisa Fox and The Tapfin team!"
Please see full press release here: https://pharmaceuticalstrategies.com/pharmaceutical-strategies-identified-as-a-premier-partner-of-tapfin/